These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tanshinone IIA inhibits acute promyelocytic leukemia cell proliferation and induces their apoptosis in vivo. Zhang K; Li J; Meng W; Xing H; Yang Y Blood Cells Mol Dis; 2016 Jan; 56(1):46-52. PubMed ID: 26603724 [TBL] [Abstract][Full Text] [Related]
4. [Enhancement of all-trans retinoic acid-induced differentiation by bufalin in primary culture of acute promyelocytic leukemia cells]. Zhu ZT; Jin B; Liu YP; Li YC; Lu XL; Tian X; Hou KZ Zhonghua Nei Ke Za Zhi; 2006 Apr; 45(4):314-7. PubMed ID: 16780682 [TBL] [Abstract][Full Text] [Related]
5. Metformin induces differentiation in acute promyelocytic leukemia by activating the MEK/ERK signaling pathway. Huai L; Wang C; Zhang C; Li Q; Chen Y; Jia Y; Li Y; Xing H; Tian Z; Rao Q; Wang M; Wang J Biochem Biophys Res Commun; 2012 Jun; 422(3):398-404. PubMed ID: 22575507 [TBL] [Abstract][Full Text] [Related]
6. WEB-2086 and WEB-2170 trigger apoptosis in both ATRA-sensitive and -resistant promyelocytic leukemia cells and greatly enhance ATRA differentiation potential. Laurenzana A; Cellai C; Vannucchi AM; Pancrazzi A; Romanelli MN; Paoletti F Leukemia; 2005 Mar; 19(3):390-5. PubMed ID: 15674364 [TBL] [Abstract][Full Text] [Related]
7. The use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia. Zhang P J Biol Regul Homeost Agents; 1999; 13(4):195-200. PubMed ID: 10703942 [TBL] [Abstract][Full Text] [Related]
8. LG-362B targets PML-RARα and blocks ATRA resistance of acute promyelocytic leukemia. Wang X; Lin Q; Lv F; Liu N; Xu Y; Liu M; Chen Y; Yi Z Leukemia; 2016 Jul; 30(7):1465-74. PubMed ID: 27012866 [TBL] [Abstract][Full Text] [Related]
9. Progress in differentiation induction as a treatment for acute promyelocytic leukemia and beyond. Lo Coco F; Zelent A; Kimchi A; Carducci M; Gore SD; Waxman S Cancer Res; 2002 Oct; 62(19):5618-21. PubMed ID: 12359776 [TBL] [Abstract][Full Text] [Related]
10. Retinoic acid therapy served by ligands cross linking and masking CD38. Yen A Leuk Res; 2007 Apr; 31(4):423-5. PubMed ID: 16914201 [No Abstract] [Full Text] [Related]
11. Acute promyelocytic leukemia: a paradigm for differentiation therapy. Grimwade D; Mistry AR; Solomon E; Guidez F Cancer Treat Res; 2010; 145():219-35. PubMed ID: 20306254 [TBL] [Abstract][Full Text] [Related]
12. Salinomycin induces apoptosis and differentiation in human acute promyelocytic leukemia cells. Zhao Y; Zhong L; Liu L; Yao SF; Chen M; Li LW; Shan ZL; Xiao CL; Gan LG; Xu T; Liu BZ Oncol Rep; 2018 Aug; 40(2):877-886. PubMed ID: 29989650 [TBL] [Abstract][Full Text] [Related]
13. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins. Rego EM; He LZ; Warrell RP; Wang ZG; Pandolfi PP Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10173-8. PubMed ID: 10954752 [TBL] [Abstract][Full Text] [Related]
14. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide. Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245 [TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide, a therapeutic agent for APL. Zhang TD; Chen GQ; Wang ZG; Wang ZY; Chen SJ; Chen Z Oncogene; 2001 Oct; 20(49):7146-53. PubMed ID: 11704843 [TBL] [Abstract][Full Text] [Related]